Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

NCT01720264 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Acute Lymphoid Leukemia
Hematopoetic Myelodysplasia
Leukemia, Myelogenous, Chronic
Lymphoma, Non-Hodgkin

Interventions

DRUG: Sitagliptin

Sponsor

Sherif S. Farag

Collaborators

[object Object]